Essayer OR - Gratuit
Micronclean Targets Sales Growth For Cleanroom Consumables In India With Biospan Contamination Control Services
Bio Spectrum
|September 2019
In 2017 Micronclean partnered with Biospan to sell its Cleanroom Consumables into the rapidly expanding Indian Pharmaceutical Cleanroom Market. Together they formed a joint venture company Biospan Contamination Control Services so that customers in India could benefit from a product range that has been sold into over 30 countries in the last 5 years.
-
Which customers does Biospan already deal with in India?
As a company Biospan already supplies some of leading Indian Bio-pharmaceutical and Pharmaceutical companies including Baxter Healthcare, Biocon, Dr Reddy’s, Intas, IPCA, Pfizer and Syngene.
As a customer what should I be looking for in an Indian Cleanroom Consumables Supplier?
As a customer I think you should ask any potential consumable supplier the following key questions and then make your assessment about who you deal with based on their replies:
1. Do you have knowledge of the local market?
2. Is the Sales team knowledgeable, experienced
and have they been directly trained in the products they are selling?
3. Do they offer in region stocking and transport facilities?
4. Do they sell market leading products or are they me to?
5. Do they have access to the technical experts who developed the product?
Note your preference will always be based on how you rate the risk associated with any of these answers.
OK so does Biospan have knowledge of the local market?
One of the things that attracted Micronclean to Biospan in the first place was there long association with the Indian Pharmaceutical market in addition to their willingness to work with us to sell our products into the Indian marketplace. As a result, we formed the joint venture company Biospan Contamination Control Solutions (Biospan CCS).
So does Biospan CCS have experienced sales teams and are they trained in the product they are selling?
Cette histoire est tirée de l'édition September 2019 de Bio Spectrum.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Bio Spectrum
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 mins
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 mins
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 mins
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 mins
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 mins
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 mins
March 2026
Translate
Change font size

